Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.
Bosen YouYin SunJie LuoKeliang WangQing LiuRuizhe FangBingmei LiuFuju ChouRonghao WangJialin MengChi-Ping HuangShuyuan YehChawnshang ChangWanhai XuPublished in: Oncogene (2021)
While the androgen receptor (AR) may influence the progression of clear cell renal cell carcinoma (ccRCC), its role to impact vasculogenic mimicry (VM) to alter the ccRCC progression and metastasis remains obscure. Here, we demonstrated that elevated AR expression was positively correlated with tumor-originated vasculogenesis in ccRCC patients. Consistently, in vitro research revealed AR promoted VM formation in ccRCC cell lines via modulating lncRNA-TANAR/TWIST1 signals. Mechanism dissection showed that AR could increase lncRNA-TANAR (TANAR) expression through binding to the androgen response elements (AREs) located in its promoter region. Moreover, we found that TANAR could impede nonsense-mediated mRNA decay (NMD) of TWIST1 mRNA by direct interaction with TWIST1 5'UTR. A preclinical study using in vivo mouse model with orthotopic xenografts of ccRCC cells further confirmed the in vitro data. Together, these results illustrated that AR-mediated TANAR signals might play a crucial role in ccRCC VM formation and metastasis, and targeting this newly identified AR/TANAR/TWIST1 signaling may help in the development of a novel anti-angiogenesis therapy to better suppress the ccRCC progression.
Keyphrases
- epithelial mesenchymal transition
- renal cell carcinoma
- poor prognosis
- long non coding rna
- mouse model
- end stage renal disease
- ejection fraction
- chronic kidney disease
- signaling pathway
- transcription factor
- dna methylation
- stem cells
- cancer therapy
- peritoneal dialysis
- mesenchymal stem cells
- cell therapy
- drug delivery
- electronic health record
- oxidative stress
- deep learning
- replacement therapy
- data analysis
- endoplasmic reticulum stress